Bausch & Lomb (FRA:S2L) Days Sales Outstanding : 63.75 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Days Sales Outstanding?

Bausch & Lomb's average Accounts Receivable for the three months ended in Dec. 2023 was €752 Mil. Bausch & Lomb's Revenue for the three months ended in Dec. 2023 was €1,076 Mil. Hence, Bausch & Lomb's Days Sales Outstanding for the three months ended in Dec. 2023 was 63.75.

The historical rank and industry rank for Bausch & Lomb's Days Sales Outstanding or its related term are showing as below:

FRA:S2L' s Days Sales Outstanding Range Over the Past 10 Years
Min: 66.24 Med: 68.88 Max: 73.71
Current: 67.92

During the past 6 years, Bausch & Lomb's highest Days Sales Outstanding was 73.71. The lowest was 66.24. And the median was 68.88.

FRA:S2L's Days Sales Outstanding is ranked worse than
53.9% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 64.61 vs FRA:S2L: 67.92

Bausch & Lomb's Days Sales Outstanding declined from Dec. 2022 (66.74) to Dec. 2023 (63.75).

Bausch & Lomb Days Sales Outstanding Historical Data

The historical data trend for Bausch & Lomb's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Days Sales Outstanding Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

68.88

76.26

63.99

67.80

69.74

Bausch & Lomb Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial											66.74	70.85	66.72	70.78	63.75

Competitive Comparison of Bausch & Lomb's Days Sales Outstanding

For the Medical Instruments & Supplies subindustry, Bausch & Lomb's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bausch & Lomb's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bausch & Lomb's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Bausch & Lomb's Days Sales Outstanding falls into.

Bausch & Lomb Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Bausch & Lomb's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (683.456	+	769.363)	/	2 )	/	3801.882	*	365
=	726.4095					/	3801.882	*	365
=	69.74

Bausch & Lomb's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (733.671	+	769.363)	/	2 )	/	1075.641	*	365 / 4
=	751.517					/	1075.641	*	365 / 4
=	63.75

Bausch & Lomb (FRA:S2L) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Bausch & Lomb Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb (FRA:S2L) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (FRA:S2L) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

BLCO:USA BLCO:Canada

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Bausch & Lomb (FRA:S2L) Headlines

No Headlines